BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31757767)

  • 21. Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus.
    Yasuhara A; Yamayoshi S; Kiso M; Sakai-Tagawa Y; Koga M; Adachi E; Kikuchi T; Wang IH; Yamada S; Kawaoka Y
    Nat Microbiol; 2019 Jun; 4(6):1024-1034. PubMed ID: 30886361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies.
    Gao J; Couzens L; Burke DF; Wan H; Wilson P; Memoli MJ; Xu X; Harvey R; Wrammert J; Ahmed R; Taubenberger JK; Smith DJ; Fouchier RAM; Eichelberger MC
    mBio; 2019 Apr; 10(2):. PubMed ID: 30967460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase.
    Lei R; Kim W; Lv H; Mou Z; Scherm MJ; Schmitz AJ; Turner JS; Tan TJC; Wang Y; Ouyang WO; Liang W; Rivera-Cardona J; Teo C; Graham CS; Brooke CB; Presti RM; Mok CKP; Krammer F; Dai X; Ellebedy AH; Wu NC
    Immunity; 2023 Nov; 56(11):2621-2634.e6. PubMed ID: 37967533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus.
    Ito M; Yamayoshi S; Murakami K; Saito K; Motojima A; Nakaishi K; Kawaoka Y
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30754701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid isolation of a potent human antibody against H7N9 influenza virus from an infected patient.
    Li J; Yang Y; Wang M; Ren X; Yang Z; Liu L; Zhang G; Chen Q; Yang W; Chen YH; Wan X
    Antiviral Res; 2019 Oct; 170():104564. PubMed ID: 31336147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases.
    Yasuhara A; Yamayoshi S; Kiso M; Sakai-Tagawa Y; Okuda M; Kawaoka Y
    Nat Commun; 2022 Nov; 13(1):6602. PubMed ID: 36329075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase.
    Meseda CA; Atukorale V; Soto J; Eichelberger MC; Gao J; Wang W; Weiss CD; Weir JP
    Sci Rep; 2018 Mar; 8(1):5364. PubMed ID: 29599502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Two Human Monoclonal Antibodies Neutralizing Influenza A H7N9 Viruses.
    Wang J; Chen Z; Bao L; Zhang W; Xue Y; Pang X; Zhang X; Qin C; Jin Q
    J Virol; 2015 Sep; 89(17):9115-8. PubMed ID: 26063436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunobiological properties of influenza A (H7N9) hemagglutinin and neuraminidase proteins.
    Jiang L; Changsom D; Lerdsamran H; Wiriyarat W; Masamae W; Noisumdaeng P; Jongkaewwattana A; Puthavathana P
    Arch Virol; 2016 Oct; 161(10):2693-704. PubMed ID: 27406044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.
    Schmeisser F; Vasudevan A; Verma S; Wang W; Alvarado E; Weiss C; Atukorale V; Meseda C; Weir JP
    PLoS One; 2015; 10(1):e0117108. PubMed ID: 25629172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9.
    Tarrahimofrad H; Rahimnahal S; Zamani J; Jahangirian E; Aminzadeh S
    Sci Rep; 2021 Dec; 11(1):24485. PubMed ID: 34966175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.
    Wohlbold TJ; Podolsky KA; Chromikova V; Kirkpatrick E; Falconieri V; Meade P; Amanat F; Tan J; tenOever BR; Tan GS; Subramaniam S; Palese P; Krammer F
    Nat Microbiol; 2017 Oct; 2(10):1415-1424. PubMed ID: 28827718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding.
    Gentles LE; Wan H; Eichelberger MC; Bloom JD
    Viruses; 2020 May; 12(6):. PubMed ID: 32486222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A sandwich ELISA for the detection of neuraminidase of avian influenza A(H7N9) virus.
    Yu Y; Zhang X; Zhao B; Sun Y; Zhang X; Bai T; Lu J; Li Z; Liu L; Wang D; Shu Y; Zhou J; Qin K
    J Virol Methods; 2017 Sep; 247():58-60. PubMed ID: 28551451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
    Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
    Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic Fingerprinting of Antibody Response in Humans following Exposure to Highly Pathogenic H7N7 Avian Influenza Virus: Evidence for Anti-PA-X Antibodies.
    Khurana S; Chung KY; Coyle EM; Meijer A; Golding H
    J Virol; 2016 Oct; 90(20):9383-93. PubMed ID: 27512055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection against lethal influenza with neuraminidase.
    Webster RG; Reay PA; Laver WG
    Virology; 1988 May; 164(1):230-7. PubMed ID: 2452514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells.
    Piepenbrink MS; Nogales A; Basu M; Fucile CF; Liesveld JL; Keefer MC; Rosenberg AF; Martinez-Sobrido L; Kobie JJ
    mBio; 2019 Mar; 10(2):. PubMed ID: 30862743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.